Asia’s Most Substantial Clinical Outsourcing Congress. Shanghai, China February 2014

The growth of clinical activities in Asia and Asia Pacific is so significant that industry leaders believe that the Asia market will overtake the US by 2020. With the increasing interest these recent years, the congress will explore into discussing issues such as global and local clinical development strategies in oncology and other therapeutic areas in order to maximize the success from CRO selection.

 

Attend our 3^rd Annual Clinical Trials & Outsourcing Asia Congress to explore into the invaluable insights of novel clinical development, clinical outsourcing strategies, biomarker clinical research and clinical trial management. Join us at InterContinental Hotel Shanghai, Pudong on 27^th & 28^th February 2014, this insightful event will attract over 150 senior level decision markers representing leading biotech companies, global pharma organisations and internationally renowned academic institutions.

 

New focus

Pharmaceutical companies have put substantial efforts into research to discover biomarkers yet there is still a long way to go to translate this into clinical practice. The next step in the process for pharmaceuticals is to qualify and validate the application of biomarkers before they can be safely used in clinical practice. Therefore, with the new Biomarkers stream addition to the 3^rd Annual Clinical Trials & Outsourcing Asia Congress, this event is not to be missed.

 

To build on the clinical case studies shared at last year’s event, we are pleased to introduce the co-located ‘4^th Annual Pharma R&D Asia Congress’ focusing on discussions on innovative strategies to overcome these R&D issues and help accelerate development pipelines.

Speakers of the 3^rd Annual Clinical Trials & Outsourcing Asia Congress include:

        ·     Jun Bao, Senior Vice President, Shenogen Pharma Group, China

        ·     Matthias Boedding, Global Safety Leader, Global Pharmacovigilance – Risk Management, Global R&D Center Beijing, Bayer Healthcare, China

        ·     Robert Chen, Vice President, Global Strategy & Partnering, Genor BioPharma, China

Taking place on 27^th&28^th February 2014 at InterContinental Hotel Shanghai, Pudong, contact Freda Shi at Oxford Global on f.shi@oxfordglobalasia.com or call +65 6570 2208 for the full agenda and prices for attendance.